| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Labcorp Holdings Inc. (LH) has 24 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. LH is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 107.2K | $27.35M | - | |
| VP | 36.5K | $9.31M | - | |
| COO | 12.7K | $3.23M | - | |
| VP | 7.9K | $2.01M | - | |
| VP | 6.7K | $1.72M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 7, 2022 | Schroeder Mark S56 | EVP, President-diagnostics Lab | Sale+OE | 204 | $277.38 | $56,585.52 | -3.0% | -12.1% | -9.2% | |
| Feb 7, 2022 | Van Der Vaart Sandra D60 | EVP, Chief Legal Officer | Sale+OE | 218 | $277.38 | $60,468.84 | -4.0% | -12.1% | -9.2% | |
| Feb 3, 2022 | Schroeder Mark S56 | EVP, President-diagnostics Lab | Sale+OE | 161 | $271.81 | $43,761.41 | -2.5% | -8.8% | -9.5% | |
| Feb 3, 2022 | Van Der Vaart Sandra D60 | EVP, Chief Legal Officer | Sale+OE | 172 | $271.81 | $46,751.32 | -3.2% | -8.8% | -9.5% | |
| Dec 15, 2021 | Gilliland Dwight Gary49 | Director | Sell | 500 | $302.26 | $151,127.83 | -1.9% | -11.6% | -24.7% | |
| Sep 15, 2021 | Van Der Vaart Sandra D60 | EVP, Chief Legal Officer | Sale+OE | 4,500 | $296.78 | $1,335,510.00 | -46.1% | -1.7% | -24.8% | |
| Jun 7, 2021 | Van Der Vaart Sandra D60 | EVP, Chief Legal Officer | Sale+OE | 4,500 | $266.56 | $1,199,520.00 | -46.2% | +14.9% | -6.8% | |
| May 6, 2021 | Kirchgraber Paul R | CEO, Covance Drug Development | Sell | 2,500 | $276.55 | $691,375.00 | -24.2% | +7.9% | -9.6% | |
| May 3, 2021 | Belingard Jean-Luc | Director | Sale+OE | 2,600 | $269.16 | $699,803.26 | -14.3% | +11.3% | -8.2% | |
| Mar 30, 2021 | Schroeder Mark S56 | EVP, President-diagnostics Lab | Sell | 667 | $251.88 | $168,003.96 | -11.8% | +6.5% | +6.1% |